Diagnosis of chlamydia pneumoniae infection is challenging due to its finicky nature as a pathogen, considerable seroprevalence, and the possibility of transient infection asymptomatic transport. Established diagnostic laboratory methods include isolated cell cultures, serological assays, and organisms in PCR. Microimmunofluorescence assay (MIF) is the current “gold standard” in serological diagnosis, but the test still lacks standardization and is technically challenging. Antibody immunoassay is the most commonly used serological test and primary chlamydia infection is characterized by significant IgM response within 2 to 4 weeks and delayed IgG and IgA response within 6 to 8 weeks. However, in reinfection, IgG and IgA levels rise rapidly, usually within 1-2 weeks, but IgM levels may rarely be detected. Thus, IgA antibodies have proven to be a reliable immune marker for primary, chronic, and recurrent infections, especially when combined with IgM testing.

Chlamydia pneumoniae IgG/IgM Rapid Test Kit is based on qualitative principle immunochromatographic determination of Chlamydia pneumoniae IgG/IgM antibodies in human serum, plasma, or whole blood.
StripA consists of: 1) a purple-red conjugated pad containing Clostridium pneumoniae bound to colloidal gold antigens (Chlamydia pneumoniae antigen conjugate)

2) Contains a test band (T band) and a control band (C band). The T band is pre-coated with mouse anti-human IgG antibody, and the C band is pre-coated with goat anti-mouse IgG antibody.
StripB consists of: 1) a purple-red binding pad containing Clostridium pneumoniae and colloidal gold bound antigens (Chlamydia pneumoniae antigen conjugate)

2) Contains a test band (T band) and a control band (C band). The T band is pre-coated with mouse anti-human IgM antibody and the C band is pre-coated with goat anti-mouse IgG antibody.